Ayala Pharmaceuticals, Inc.
(NASDAQ GM: AYLA)
Rigrodsky Law, P.A. is investigating Ayala Pharmaceuticals, Inc. (“Ayala”) regarding possible breaches of fiduciary duties and other violations of law related to Ayala’s agreement to merge with Advaxis, Inc. (“Advaxis”). Under the terms of the agreement, Ayala shareholders will receive 0.1874 shares of Advaxis common stock for each share of Ayala common stock.